Starcher B C, Goldstein R A
J Lab Clin Med. 1979 Dec;94(6):848-52.
Intestinal absorption of desmosine and isodesmosine was investigated in several animal species. Hamsters given desmosine injections intraperitoneally excreted 70% of the injected dose in the urine. When desmosines or elastin were given via gastric intubation, desmosines failed to appear in the urine, indicating a lack of desmosine absorption. Additional studies with everted hamster intestine in vitro showed that norleucine was actively transported from the mucosal to the serosal side but that desmosines and lysinonorleucine were not transported. Intestinal slice experiments with hamster, rabbit, and dog intestine indicated desmosines only in the extracellular space and not absorbed by the mucosal cells. These studies strongly suggest that desmosines are not absorbed via the gastrointestinal tract. The importance of this study rests with the conclusion that desmosines recovered in the urine must represent the degradation products of elastin destruction in the tissue. Newly synthesized elastin cannot interfre, since elastin precursor molecules do not contain desmosines. Thus quantitation of urinary desmosines may be of clinical value as a method of evaluating elastin catabolism.
在几种动物物种中研究了异锁链素和异异锁链素的肠道吸收情况。经腹腔注射异锁链素的仓鼠,尿液中排出了注射剂量的70%。当通过胃插管给予异锁链素或弹性蛋白时,尿液中未出现异锁链素,表明异锁链素缺乏吸收。对体外翻转的仓鼠肠道进行的其他研究表明,正亮氨酸从黏膜侧被主动转运至浆膜侧,但异锁链素和赖氨酰正亮氨酸未被转运。用仓鼠、兔子和狗的肠道进行的肠切片实验表明,异锁链素仅存在于细胞外空间,未被黏膜细胞吸收。这些研究有力地表明,异锁链素不会通过胃肠道吸收。这项研究的重要性在于得出这样的结论:尿液中回收的异锁链素必定代表组织中弹性蛋白破坏的降解产物。新合成的弹性蛋白不会干扰,因为弹性蛋白前体分子不含异锁链素。因此,尿液异锁链素的定量作为评估弹性蛋白分解代谢的一种方法可能具有临床价值。